Helpful Links & Resources
Reading Time: 5 mins
Published On: June 22, 2019
Matthew Davis - author
Matthew Davis is a freelance journalist who has covered civil litigation for a variety of publications. He joined Mesowatch in 2016 and covers asbestos litigation developments in the U.S., as well as newsworthy asbestos cases.
More to Read
August 24, 2024
Talc Settlement Disputes Keep Doors Open for Future Claims Against J&J
>READ
August 22, 2024
GAG-DP Biomaterial Advances Mesothelioma Research
>READ
August 21, 2024
$59.7M Transfer Triggers Legal Battle Over Asbestos Claims
>READ
August 18, 2024
Pleural and Peritoneal Mesothelioma Found in Female Patient
>READ
August 17, 2024
Study Finds State-Level Trends and Asbestos-Talc Risks
>READ
August 16, 2024
What The J&J $63.4M Talc Lung Cancer Verdict Means for You
>READ
News & Data
FILTER:
Amna Anees
5 mins read - August 28, 2024
In a groundbreaking development, the U.S. Food and Drug Administration (FDA) has granted Investigational New Drug (IND) clearance to Insilico Medicine’s ISM6331, a potential...
Melissa Bill
5 mins read - August 27, 2024
The consumer products behemoth Johnson & Johnson is now submerged under a barrage of lawsuits accusing the company’s talc-based products of being the root cause of their...
Katie Duquette
6 mins read - August 26, 2024
Asbestos lawsuits are critical for individuals diagnosed with mesothelioma, lung cancer, or other asbestos-related ailments. Such diagnoses can lead to major life adjustments, and...
Matthew Davis
4 mins read - August 24, 2024
The complex negotiations surrounding Johnson & Johnson’s $6.5 billion attempt to settle thousands of lawsuits regarding its talc products have hit a stumbling block,...
Amna Anees
2 mins read - August 22, 2024
A new biomaterial researchers have developed called GAG-DP is making a significant advancement when it comes to mesothelioma treatment. This has the potential to revolutionize...
Matthew Davis
3 mins read - August 21, 2024
Former executives of Nash Engineering Co. are grappling with serious allegations from a Chapter 7 bankruptcy trustee. The lawsuit which is taking place in Connecticut accuses the...
August 18, 2024
Pleural and Peritoneal Mesothelioma Found in Female Patient
>READ
August 17, 2024
Study Finds State-Level Trends and Asbestos-Talc Risks
>READ
August 16, 2024
What The J&J $63.4M Talc Lung Cancer Verdict Means for You
>READ
August 16, 2024
The End of Asbestos: EPA’s Historic Ban and Its Implications
>READ
August 16, 2024
Talc Lung Cancer Lawsuit Costs Johnson & Johnson $63.4 Million
>READ
August 15, 2024
PET/CT Enhancing Diagnosis and Treatment of Pleural Mesothelioma
>READ
August 14, 2024
Secondary Exposure Emerges as a Hidden Threat in the Ongoing Asbestos Crisis
>READ
August 13, 2024
Avon’s Financial Turmoil: Chapter 11 Bankruptcy Amid Talc-Related Cancer Lawsuits
>READ
August 12, 2024
Research Supports DHA Treatment as Effective for Pleural Mesothelioma Patients
>READ
Browse Categories
Information provided by Mesowatch aims to provide legal and financial assistance and should not be considered a substitute for medical advice, treatment or diagnosis. Past performance and settlements do not guarantee or indicate the outcome of an individual case. Viewing this information or interacting with this website does not create an attorney-client relationship.